Vernakalant: A novel agent for the termination of atrial fibrillation
Author:
Affiliation:
1. College of Pharmacy, University of Oklahoma, Schusterman Center #2H19, 4502 E. 41st Street, Tulsa, OK 74135-2512
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/67/14/1157/28344446/ajhp1157.pdf
Reference47 articles.
1. Status of the epidemiology of atrial fibrillation;Kannel;Med Clin North Am,2008
2. Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004;McDonald;Ann Emerg Med,2008
3. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study;Go;JAMA,2001
4. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence;Miyasaka;Circulation,2006
5. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population based estimates;Kannel;Am J Cardiol,1998
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario;Kardiologia Polska;2020-11-25
2. Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice;Future Cardiology;2020-11
3. Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping;Stem Cells Translational Medicine;2020-09-14
4. Drug Screening Platform Using Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes and Optical Mapping;2020-07-15
5. Vernakalant in Atrial Fibrillation: A Relatively New Weapon in the Armamentarium Against an Old Enemy;DRUG TARGET INSIGHT;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3